In Treatment of Severe bacterial infections Linopik OD Tablet SR works by killing bacteria which can cause serious infections. It is used to treat many different types of bacterial infections such as infections of lungs (pneumonia), skin, and soft tissues. This medicine usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
It is unsafe to consume alcohol with Linopik OD Tablet SR.
Linopik OD Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Linopik OD Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Linopik OD Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Linopik OD Tablet SR is safe to use in patients with kidney disease. No dose adjustment of Linopik OD Tablet SR is recommended. However, talk to your doctor if you have any underlying kidney disease.
Linopik OD Tablet SR should be used with caution in patients with severe liver disease. Dose adjustment of Linopik OD Tablet SR may be needed. Please consult your doctor. Limited information is available on the use of Linopik OD Tablet SR in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
If you miss a dose of Linopik OD Tablet SR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Zuventus Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Norgam Medicaments Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)